Keymed Biosciences Inc (2162.HK)
Company Info
| ISIN | KYG5252B1023 |
|---|---|
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | HK$14.29B |
|---|---|
| EPS | HK$0.00 |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue (TTM) | HK$100.06M |
| Gross Profit (TTM) | HK$97.48M |
| EBITDA (TTM) | -HK$522.22M |
| Year Range | HK$22.10 - HK$82.85 |
| Target Price | HK$81.96 |
Share Price Chart
Loading data...
Performance
The chart shows the growth of an initial investment of HK$10,000 in Keymed Biosciences Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
Return
Keymed Biosciences Inc had a return of 0.20% year-to-date (YTD) and 124.12% in the last 12 months. Over the past 10 years, Keymed Biosciences Inc had an annualized return of -14.40%, outperforming the S&P 500 benchmark which had an annualized return of -4.05%.
| Period | Return | Benchmark |
|---|---|---|
| 1 month | -18.24% | -0.59% |
| Year-To-Date | 0.20% | 7.47% |
| 6 months | -4.58% | 4.51% |
| 1 year | 124.12% | -4.20% |
| 5 years (annualized) | -14.40% | -4.05% |
| 10 years (annualized) | -14.40% | -4.05% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 31.76% | -6.25% | -7.94% | 7.76% | ||||||||
| 2022 | 26.40% | 12.33% | 0.89% |
Risk-Adjusted Performance
This table presents a comparison of risk-adjusted performance metrics for Keymed Biosciences Inc (2162.HK) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
|---|---|---|---|---|---|
2162.HK Keymed Biosciences Inc | 1.99 | ||||
^GSPC S&P 500 | 0.27 |
Dividend History
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below shows the maximum drawdowns of the Keymed Biosciences Inc. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Keymed Biosciences Inc is 74.71%, recorded on Mar 21, 2022. It took 212 trading sessions for the portfolio to recover.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -74.71% | Jul 14, 2021 | 171 | Mar 21, 2022 | 212 | Feb 1, 2023 | 383 |
| -35.48% | Feb 3, 2023 | 76 | May 25, 2023 | — | — | — |
Volatility Chart
The current Keymed Biosciences Inc volatility is 14.02%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.